文献速递慢性肾脏病血液净化与透析肾移植

COVID-19与慢性肾脏病患者的心血管疾病

COVID-19 and cardiovascular disease in patients with chronic kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2024-01-01

全球慢性肾脏病(CKD)患者众多,因多种原因心血管疾病风险高。CKD与更严重的SARS-CoV-2感染相关,透析或肾移植患者尤其如此。本文综述COVID-19的心血管并发症及其对CKD人群的影响。

要点

  • CKD患者心血管疾病风险高,且与更严重的SARS-CoV-2感染相关
  • 透析或肾移植患者感染SARS-CoV-2后重症风险尤其突出
  • COVID-19心血管并发症可发生于急性期及康复后数月

核心结论

  • CKD患者是SARS-CoV-2感染重症的高危人群,透析或肾移植患者尤其如此;COVID-19相关心血管并发症可发生于感染急性期及康复后数月,其机制涉及病毒直接细胞病变、内皮损伤和高凝状态。

研究设计与样本

  • 综述,聚焦COVID-19的心血管并发症及其对CKD人群的影响。

主要发现

  • 感染SARS-CoV-2后观察到的心血管并发症包括急性炎症表现、心血管事件、血栓事件和心律失常。
  • 已提出的致病机制包括病毒对心肌的直接细胞病变效应、内皮损伤和高凝状态。
  • 上述疾病谱可发生于感染急性期,也可发生于康复后数月。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Millions of people worldwide have chronic kidney disease (CKD). Affected patients are at high risk for cardiovascular (CV) disease for several reasons. Among various comorbidities, CKD is associated with the more severe forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This is particularly true for patients receiving dialysis or for kidney recipients. From the start of the SARS-CoV-2 pandemic, several CV complications have been observed in affected subjects, spanning acute inflammatory manifestations, CV events, thrombotic episodes and arrythmias. Several pathogenetic mechanisms have been hypothesized, including direct cytopathic viral effects on the myocardium, endothelial damage and hypercoagulability. This spectrum of disease can occur during the acute phase of the infection, but also months after recovery. This review is focussed on the CV complications of coronavirus disease 2019 (COVID-19) with particular interest in their implications for the CKD population.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Del Vecchio L, Balafa O, Dounousi E, et al. COVID-19 and cardiovascular disease in patients with chronic kidney disease. Nephrol Dial Transplant. 2024. PMID: 37771078. doi:10.1093/ndt/gfad170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。